Page last updated: 2024-11-06

hydroxyproline and Adrenal Cancer

hydroxyproline has been researched along with Adrenal Cancer in 1 studies

Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.

Research Excerpts

ExcerptRelevanceReference
"This hypercalcemia was accompanied by marked urinary hydroxyproline excretion and less calcium excretion in the urine than the prevailing level of serum calcium."1.27Hypercalcemia in glucocorticoid withdrawal. ( Fukumoto, Y; Ichihara, K; Itoh, Y; Miyazaki, A; Moriwaki, K; Nonaka, K; Seino, Y; Suzuki, K; Tarui, S; Yamada, Y, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Suzuki, K1
Nonaka, K1
Ichihara, K1
Fukumoto, Y1
Miyazaki, A1
Yamada, Y1
Itoh, Y1
Seino, Y1
Moriwaki, K1
Tarui, S1

Other Studies

1 other study available for hydroxyproline and Adrenal Cancer

ArticleYear
Hypercalcemia in glucocorticoid withdrawal.
    Endocrinologia japonica, 1986, Volume: 33, Issue:2

    Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Calcium; Female; Glucocorticoids; Humans; Hydroxypr

1986